Paseon-hosted Virus Vector Seminar 2026
Gene therapy, particularly modalities using AAV, is garnering significant expectations; however, the high manufacturing costs and challenges in scaling up present major obstacles to practical application.
In this seminar, we will introduce practical approaches to optimize costs and development timelines while maintaining high quality, based on insights gained from supporting numerous projects as a global CDMO.
On the day of the event, in addition to presentations by experts active at the forefront globally, we will have a panel discussion featuring Kazunobu Oyama, Executive Officer of Onodera GT Pharma, a Japanese biotech venture developing gene therapies, and Sota Yoshizawa, also an Executive Officer. They will discuss a wide range of topics, including the challenges currently faced in the development and manufacturing of viral vectors and regulatory compliance.
Event Overview
Date: April 24, 2026 (Friday) 15:00-18:00 (Registration starts at 14:30)
Location: Thermo Fisher Scientific Japan Group
Regenerative Medicine Creative Experience Lab (Shibaura, Tokyo)
Pre-registration is required (limited capacity).
Please apply through the Paseon site.

| Date and time | Friday, Apr 24, 2026 |
|---|---|
| Capital | Thermo Fisher Scientific Japan Group Regenerative Medicine Creative Experience Lab |
| Entry fee | Free |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration




